accordance with the ACCME Standards for Integrity and Independence, the
Association of Diabetes Care & Education Specialists (ADCES) requires
anyone in a position to affect or control continuing education content (e.g.,
authors, presenters, and program planners) to disclose all financial
relationships with ineligible companies. It is the responsibility of ADCES to
mitigate and disclose all relevant conflicts of interest. Disclosure of a
relationship is not intended to suggest or condone bias in any presentation but
is made to provide participants with information that might be of potential
importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Sacha Uelmen, RDN, CDCES – No conflicts of interest
Amy Carter, RDN, CDCES – No conflicts of interest
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM – Stock: Gilead Sciences, Regeneron Pharma
Uelmen, RDN, CDCES – No conflicts of interest
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Mitigation of Relevant Conflicts of Interest
relevant conflicts of interest have been mitigated.
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes